Funding

Latest News

Impact Factor ...

Significant rise in impact factors for ISC journals, IJAA and JGAR

Read More
ICC 2017 Taipei, Taiwan ...

29 June 2017 is the final deadline for ICC 2017 abstract submission ...

Read More

A new ISC Fellowship Programme was created to host researchers in the early stages of their careers to develop their research and/or clinical experience in institutions outside their region. Young colleagues were invited to learn from experienced specialists within the ISC and to take home new ideas and processes that help them improve their clinical or laboratory practice.

The first two fellowships were awarded in 2013. Funding was provided for up to three months up to a maximum of the equivalent of 10,000 US Dollars to cover travel costs and living expenses. The Fellowships have been designed to support research, not course studies.

For 2013, applications were invited from young scientists (physicians, microbiologists, and pharmacists) to spend time in Italy, the United Kingdom or Taiwan, working on the topics detailed in the application form. Applicants had to be 35 years of age or younger, and had to hold a position at a medical, university, research, veterinary or public health institution. Good written and spoken English is essential.

Further ISC Fellowship opportunities will be announced in due course.


Dodi Safari

The first ISC Fellowship was awarded to Dodi Safari from Jakarta, Indonesia who travelled to the department of Po-Ren Hsueh in Taipei, Taiwan to investigate the “Molecular characterization of macrolide-resistant Streptococcus pneumoniae from different hospitals in Taiwan from 2006 to 2010.” His results have been written up and will be submitted to the International Journal of Antimicrobial Agents.

Ruirui He

The second ISC Fellowship was awarded to Ruirui He from Beijing, China who is currently in Florence, Italy with Teresita Mazzei and Andrea Novelli looking at “Applying the Monte Carlo Simulation method to calculate the optimal dose of new antibiotics in clinical trial”.